Skip to main content
. Author manuscript; available in PMC: 2009 Dec 4.
Published in final edited form as: Cell. 2008 Oct 31;135(3):437–448. doi: 10.1016/j.cell.2008.08.041

Figure 6. Evaluation of Imatinib Mesylate Efficacy in an Index Patient with a Plexiform Neurofibroma.

Figure 6

Coronal MRI scans (T1 weighted images with gadolinium contrast and fat saturation) of the head and oropharynx of an NF1 patient with a plexiform neurofibroma before (panel 1) and 3 months following treatment with imatinib mesylate (panel 2). The region of the tumor in the respective images is indicated.